JUBLINGREA vs KRONOX: Stock Comparison

Jubilant Ingrevia Limited vs Kronox Lab Sciences Limited

Live data: 27 July 2026, 4:08 PM IST • Source: NSE and company filings

Jubilant Ingrevia Limited is the larger company by market capitalisation. Jubilant Ingrevia Limited shows a higher dividend yield and faster revenue growth, while Kronox Lab Sciences Limited shows a lower P/E, a higher ROE and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Jubilant Ingrevia Limited and Kronox Lab Sciences Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, JUBLINGREA is more favourable on 5 of 13 scored metrics and KRONOX on 8These counts are context-free and are not an overall rating.

Key Differences

Market Cap
JUBLINGREA is the larger company
₹11,835 Cr vs ₹577 Cr
P/E Ratio
KRONOX has a lower P/E
20.7x vs 37.41x
P/B Ratio
JUBLINGREA has a lower P/B
3.69x vs 4.93x
EPS
JUBLINGREA has higher earnings per share
₹18.39 vs ₹7.45
Dividend Yield
JUBLINGREA has a higher dividend yield
0.7% vs 0.33%
Revenue Growth (TTM YoY)
JUBLINGREA has faster revenue growth
12.1% vs 0%
EPS Growth (TTM YoY)
KRONOX has faster EPS growth
26.7% vs 16.1%
Qtr Sales Growth
JUBLINGREA has stronger quarterly sales growth
12.1% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricJUBLINGREAKRONOX
SectorChemicalsChemicals
IndustrySpecialty ChemicalsSpecialty Chemicals

Price

MetricJUBLINGREAKRONOX
Live Price₹744.1₹155.55
Day Change2.56%0.75%
Volume4.46 L1.02 L
52-Week High₹845.55₹187.7
52-Week Low₹537.3₹96
Distance from 52W High-12%-17.13%

Valuation

MetricJUBLINGREAKRONOX
Market Cap₹11,835 Cr₹577 Cr
P/E Ratio37.41x20.7x
P/B Ratio3.69x4.93x
EPS₹18.39₹7.45
Book Value₹197.83₹31.64
Dividend Yield0.7%0.33%

Growth

MetricJUBLINGREAKRONOX
Revenue Growth (TTM YoY)12.1%0%
EPS Growth (TTM YoY)16.1%26.7%
Qtr Sales Growth12.1%0%
Qtr Profit Growth16.7%26.6%

Profitability & Leverage

MetricJUBLINGREAKRONOX
ROE9.51%26.8%
ROCE11.4%36%
Net Margin6.61%27.21%
Operating Margin12.9%33.9%
Debt to Equity0.25x0.01x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricJUBLINGREAKRONOX
Promoter Holding41.7%74.21%
FII Holding6.49%0.04% 0.04 pp
DII Holding24.98% 0.22 pp2.07% 0.02 pp
Public Holding22.29% 0.23 pp23.67% 0.01 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Jubilant Ingrevia Limited and Kronox Lab Sciences Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.